SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001367644-23-000135
Filing Date
2023-07-21
Accepted
2023-07-21 08:25:40
Documents
14
Period of Report
2023-07-20
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ebs-20230720.htm   iXBRL 8-K 29683
2 EX-99.1 a072023-av7909cyfendusappr.htm EX-99.1 22045
6 GRAPHIC image.jpg GRAPHIC 7489
  Complete submission text file 0001367644-23-000135.txt   198879

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ebs-20230720.xsd EX-101.SCH 1967
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ebs-20230720_lab.xml EX-101.LAB 25156
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ebs-20230720_pre.xml EX-101.PRE 13102
8 EXTRACTED XBRL INSTANCE DOCUMENT ebs-20230720_htm.xml XML 2923
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 231101143
SIC: 2834 Pharmaceutical Preparations